NM_030662.4:c.1187C>G

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PM2PP3

The NM_030662.4(MAP2K2):​c.1187C>G​(p.Thr396Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000143 in 1,399,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T396M) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

MAP2K2
NM_030662.4 missense

Scores

4
13
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 9.58

Publications

1 publications found
Variant links:
Genes affected
MAP2K2 (HGNC:6842): (mitogen-activated protein kinase kinase 2) The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008]
MAP2K2 Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cardiofaciocutaneous syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • neurofibromatosis-Noonan syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Noonan syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PM1
In a modified_residue Phosphothreonine (size 0) in uniprot entity MP2K2_HUMAN
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.792

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAP2K2NM_030662.4 linkc.1187C>G p.Thr396Arg missense_variant Exon 11 of 11 ENST00000262948.10 NP_109587.1 P36507
MAP2K2NM_001440688.1 linkc.908C>G p.Thr303Arg missense_variant Exon 9 of 9 NP_001427617.1
MAP2K2NM_001440689.1 linkc.617C>G p.Thr206Arg missense_variant Exon 9 of 9 NP_001427618.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAP2K2ENST00000262948.10 linkc.1187C>G p.Thr396Arg missense_variant Exon 11 of 11 1 NM_030662.4 ENSP00000262948.4 P36507

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000631
AC:
1
AN:
158546
AF XY:
0.0000119
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000162
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000143
AC:
2
AN:
1399846
Hom.:
0
Cov.:
31
AF XY:
0.00000290
AC XY:
2
AN XY:
690742
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31708
American (AMR)
AF:
0.00
AC:
0
AN:
35848
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25188
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35904
South Asian (SAS)
AF:
0.0000126
AC:
1
AN:
79386
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48344
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5484
European-Non Finnish (NFE)
AF:
9.26e-7
AC:
1
AN:
1079976
Other (OTH)
AF:
0.00
AC:
0
AN:
58008
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Uncertain
0.090
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.74
D;T
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.90
D;D
M_CAP
Pathogenic
0.35
D
MetaRNN
Pathogenic
0.79
D;D
MetaSVM
Uncertain
0.30
D
MutationAssessor
Uncertain
2.3
M;.
PhyloP100
9.6
PrimateAI
Uncertain
0.54
T
PROVEAN
Uncertain
-2.6
D;D
REVEL
Uncertain
0.55
Sift
Uncertain
0.014
D;D
Sift4G
Uncertain
0.0060
D;D
Polyphen
1.0
D;.
Vest4
0.68
MutPred
0.34
Gain of solvent accessibility (P = 0.0058);.;
MVP
0.79
MPC
0.60
ClinPred
0.92
D
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.26
gMVP
0.87
Mutation Taster
=31/69
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117945277; hg19: chr19-4090612; API